AU2002211563A1 - Compounds useful for treating hypertriglyceridemia - Google Patents

Compounds useful for treating hypertriglyceridemia

Info

Publication number
AU2002211563A1
AU2002211563A1 AU2002211563A AU1156302A AU2002211563A1 AU 2002211563 A1 AU2002211563 A1 AU 2002211563A1 AU 2002211563 A AU2002211563 A AU 2002211563A AU 1156302 A AU1156302 A AU 1156302A AU 2002211563 A1 AU2002211563 A1 AU 2002211563A1
Authority
AU
Australia
Prior art keywords
compounds useful
treating hypertriglyceridemia
hypertriglyceridemia
treating
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211563A
Inventor
Arthur Schwartz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AESON THERAPEUTICS Inc
Original Assignee
AESON THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AESON THERAPEUTICS Inc filed Critical AESON THERAPEUTICS Inc
Publication of AU2002211563A1 publication Critical patent/AU2002211563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002211563A 2000-10-06 2001-10-09 Compounds useful for treating hypertriglyceridemia Abandoned AU2002211563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23865900P 2000-10-06 2000-10-06
US60238659 2000-10-06
PCT/US2001/031568 WO2002028880A2 (en) 2000-10-06 2001-10-09 Compounds useful for treating hypertriglyceridemia

Publications (1)

Publication Number Publication Date
AU2002211563A1 true AU2002211563A1 (en) 2002-04-15

Family

ID=22898799

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211563A Abandoned AU2002211563A1 (en) 2000-10-06 2001-10-09 Compounds useful for treating hypertriglyceridemia

Country Status (6)

Country Link
US (1) US20040019026A1 (en)
EP (1) EP1351971A2 (en)
JP (2) JP2004510781A (en)
AU (1) AU2002211563A1 (en)
CA (1) CA2424581A1 (en)
WO (1) WO2002028880A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080015174A1 (en) * 1998-11-24 2008-01-17 Reading Christopher L Metabolic Disease Treatments
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DK1955700T3 (en) 1999-09-30 2011-05-23 Harbor Biosciences Inc Therapeutic treatment of androgen receptor-related disorders
CA2484963A1 (en) * 2002-05-01 2003-11-13 Arthur Schwartz 7-hydroxy-16a-fluoro-5-androsten-17-ones and 7-hydroxy-16a-fluoro-5-androstan-17-ones and derivatives thereof
AU2003278744B2 (en) * 2002-08-28 2010-07-29 Harbor Biosciences, Inc. Therapeutic treatment methods
CN101227892B (en) * 2005-04-08 2013-06-05 舌交付有限公司 Buccal delivery system
JP5523705B2 (en) 2005-08-29 2014-06-18 レグルス・セラピューティクス・インコーポレイテッド Method of using to modulate MIR-122A
US20070238183A1 (en) * 2006-04-04 2007-10-11 Stout Robert L Methods for assessment of cardiovascular disease risk
CA2729343C (en) 2008-06-30 2013-12-17 Arthur G. Schwartz Topical steroidal formulations
WO2011138460A1 (en) * 2010-05-07 2011-11-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Progesterone receptor antagonists and uses thereof
EP3565559A4 (en) * 2017-01-09 2020-07-08 Temple University - Of The Commonwealth System of Higher Education Methods and compositions for treatment of non-alcoholic steatohepatitis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2911418A (en) * 1959-01-02 1959-11-03 Searle & Co 16-halo 17-oxygenated androst-5-en-3-ols and esters
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
US5157031A (en) * 1983-08-02 1992-10-20 Research Corporation Technologies, Inc. Method for prophylaxis of obesity
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
PT84911B (en) * 1986-05-21 1990-02-08 Research Corp PROCESS FOR THE PREPARATION OF UTERIC STEROIDS AS ANTI-CANCERIGENE AND ANTI-OBESITY AGENTS
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5122362A (en) * 1989-12-04 1992-06-16 Board Of Regents, The University Of Texas System Methods and compositions for the measurement of glucose tolerance
US5811418A (en) * 1993-03-09 1998-09-22 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US5714418A (en) * 1995-11-08 1998-02-03 Intel Corporation Diffusion barrier for electrical interconnects in an integrated circuit
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
BR0010197A (en) * 1999-04-30 2002-07-16 Arch Dev Corp Steroid derivatives
WO2002062302A2 (en) * 2001-02-08 2002-08-15 The University Of Chicago Steroidal derivatives

Also Published As

Publication number Publication date
JP2004510781A (en) 2004-04-08
US20040019026A1 (en) 2004-01-29
EP1351971A2 (en) 2003-10-15
JP2009143925A (en) 2009-07-02
CA2424581A1 (en) 2002-04-11
WO2002028880A2 (en) 2002-04-11
WO2002028880A8 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2002225730A1 (en) Compounds
AU2002218266A1 (en) Novel indanylidene compounds
AU2002222228A1 (en) Chemical compounds
AU2001284584A1 (en) Chemical compounds
AU2001231104A1 (en) Methods for treating diabetes
AU2001262886A1 (en) Chemical compounds
AU2001228638A1 (en) Chemical compounds
AU2001292518A1 (en) Novel compounds
AU2002213887A1 (en) Process for the antimicrobial treatment of fiber materials
AU2002225930A1 (en) Methods for treating phosphatide-containing mixtures
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AU2001273609A1 (en) Process for treating wood
AU2002211563A1 (en) Compounds useful for treating hypertriglyceridemia
AU2001266486A1 (en) New compounds useful as antibacterial agents
AU2001253362A1 (en) Novel compounds
EG24462A (en) Compounds for treating fundic disaccomodation
AU2002231077A1 (en) Novel compounds
AU2001256964A1 (en) Novel compounds
AU2002225724A1 (en) Motilide compounds
AU2405002A (en) Dehalogeno compounds
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2002218440A1 (en) New process